Now showing items 1-2 of 2

    • Atypical Behaviour and Connectivity in SHANK3-Mutant Macaques 

      Zhou, Yang; Sharma, Jitendra; Yuan, Jingli; Chen, Hong; Aida, Tomomi; Yan, Ting; Zou, Ying; Xu, Dongdong; Parmar, Shivangi; Fanucci-Kiss, Adrian; Wang, Dongqing; Huang, Yan; Li, Yaqing; Bai, Yanyang; Ji, Wenjing; Lai, Xinqiang; Li, Weiqiang; Huang, Lihua; Lu, Zhonghua; Wang, Liping; Anteraper, Sheeba A.; Sur, Mriganka; Zhou, Huihui; Xiang, Andy Peng; Desimone, Robert; Feng, Guoping; Yang, Shihua; Ke, Qiong; Landman, Rogier; Hayden, David; Fisher, John; Jiang, Mingqing; Hyman, Julia; Meisner, Olivia; Menegas, William (Springer Science and Business Media LLC, 2019-06)
      Mutation or disruption of the SHANK3 (SH3 domain and ankyrin repeat) gene represents a highly penetrant, monogenic risk-factor for Autism Spectrum Disorder (ASD) and is a cause of Phelan–McDermid syndrome (PMS). Recent ...
    • Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease 

      Greenberg, Steven A.; Zivadinov, R.; Lee-Kwen, P.; Sharma, Jitendra; Planter, M.; Umhauer, M.; Glenister, N.; Bakshi, Rohit (SAGE Publications, 2016)
      Background: Patients with relapsing–remitting multiple sclerosis (RRMS) may experience breakthrough disease despite effective interferon beta (IFNβ) therapy. Fludarabine (FLU) is a chemotherapeutic agent used in ...